Quantcast

Empire State Today

Thursday, November 21, 2024

New York: Biologics companies were the third most FDA inspected companies in New York in Q4 2023

Webp r4rtnb3h764dx5zlstpe2fag0ycm

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

In the fourth quarter of 2023, 10 Biologics companies received 10 FDA inspections in New York, according to the U.S. Food and Drug Administration (FDA).

This was the third highest number of inspections per type of company made by the FDA in New York, equalling 8.8% of all inspections in the fourth quarter of 2023.

Of all the New York companies involved in the Biologics sector, New York Blood Center Enterprises received the most citations from the FDA in the fourth quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in New York During Q4 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring4----
Blood and Blood Products44--
Compliance: Devices68--
Drug Quality Assurance25--
Food Composition, Standards, Labeling and Econ42--
Foodborne Biological Hazards4422--
Human Cellular, Tissue, and Gene Therapies42--
Monitoring of Marketed Animal Drugs, Feed, and Devices31--
Postmarket Assurance: Devices131--
Technical Assistance: Food and Cosmetics41--

MORE NEWS